- Home
- ARWR vs INSW Comparison
ARWR vs INSW Comparison
Compare ARWR & INSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARWR
- INSW
- Stock Information
- Founded
- ARWR 2003
- INSW 1999
- Country
- ARWR United States
- INSW United States
- Employees
- ARWR N/A
- INSW N/A
- Industry
- ARWR Biotechnology: Pharmaceutical Preparations
- INSW Semiconductors
- Sector
- ARWR Health Care
- INSW Technology
- Exchange
- ARWR Nasdaq
- INSW Nasdaq
- Market Cap
- ARWR 1.8B
- INSW 1.8B
- IPO Year
- ARWR 1993
- INSW N/A
- Fundamental
- Price
- ARWR $17.64
- INSW $38.75
- Analyst Decision
- ARWR Buy
- INSW Buy
- Analyst Count
- ARWR 8
- INSW 2
- Target Price
- ARWR $43.71
- INSW $52.00
- AVG Volume (30 Days)
- ARWR 1.6M
- INSW 704.9K
- Earning Date
- ARWR 08-07-2025
- INSW 08-06-2025
- Dividend Yield
- ARWR N/A
- INSW 10.40%
- EPS Growth
- ARWR N/A
- INSW N/A
- EPS
- ARWR N/A
- INSW 6.47
- Revenue
- ARWR $545,209,000.00
- INSW $860,606,000.00
- Revenue This Year
- ARWR $22,384.93
- INSW N/A
- Revenue Next Year
- ARWR N/A
- INSW $1.88
- P/E Ratio
- ARWR N/A
- INSW $5.95
- Revenue Growth
- ARWR 1436.97
- INSW N/A
- 52 Week Low
- ARWR $9.57
- INSW $27.20
- 52 Week High
- ARWR $30.41
- INSW $58.73
- Technical
- Relative Strength Index (RSI)
- ARWR 68.77
- INSW 51.76
- Support Level
- ARWR $18.10
- INSW $38.59
- Resistance Level
- ARWR $19.07
- INSW $40.40
- Average True Range (ATR)
- ARWR 0.79
- INSW 1.22
- MACD
- ARWR 0.22
- INSW 0.00
- Stochastic Oscillator
- ARWR 85.75
- INSW 61.64
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
About INSW International Seaways Inc.
International Seaways Inc owns and operates a fleet of oceangoing vessels engaged in the transportation of crude oil and petroleum products. The company's vessel operations are organized into two segments: Crude Tankers and Product Carriers. The fleet consists of ULCC, VLCC, Suezmax, Aframax, and Panamax crude tankers, as well as LR1, LR2, and MR product carriers.